LABP insider filings

Landos Biopharma, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-05-23. Screen LABP transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for LABP between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Landos Biopharma, Inc.

FiledFormInsiderReported transactionsSource
2024-05-234Callori Fred — DirectorDisposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative)EDGAR
2024-05-234Batycky Alka — DirectorDisposition to issuer (D): 3,600 (derivative)EDGAR
2024-05-234Garabedian Christopher Nishan — DirectorDisposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative)EDGAR
2024-05-234Cataldi Fabio — Chief Medical OfficerDisposition to issuer (D): 48,813 (derivative) · Disposition to issuer (D): 18,449 (derivative) · Disposition to issuer (D): 39,999 (derivative)EDGAR
2024-05-234Oakes Gregory — Chief Executive Officer, DirectorDisposition to issuer (D): 54,454 (derivative) · Disposition to issuer (D): 47,529 (derivative) · Disposition to issuer (D): 167,724 (derivative)EDGAR
2024-05-234Adsett Roger — DirectorDisposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 3,600 (derivative)EDGAR
2024-05-234Girao Tiago — DirectorDisposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative)EDGAR
2024-05-234MAYLEBEN TIMOTHY M — DirectorDisposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative)EDGAR
2024-03-044Cataldi Fabio — Chief Medical OfficerGrant/award (A): 21,138 (derivative) @ $0EDGAR
2024-03-044Oakes Gregory — Chief Executive Officer, DirectorGrant/award (A): 54,454 (derivative) @ $0EDGAR
2023-06-014Batycky Alka — DirectorGrant/award (A): 3,600 (derivative) @ $0EDGAR
2023-05-244Garabedian Christopher Nishan — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-05-244Callori Fred — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-05-244Adsett Roger — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-05-244Girao Tiago — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-05-244MAYLEBEN TIMOTHY M — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2023-03-024Bassaganya-Riera Josep — 10% ownerSale (S): 3,470,736 · Sale (S): 467,306 · Sale (S): 496,527 · Sale (S): 500,000 · Sale (S): 786,299EDGAR
2023-03-024Cataldi Fabio — Chief Medical OfficerGrant/award (A): 184,500 (derivative) @ $0 · Grant/award (A): 276,750 (derivative) @ $0EDGAR
2023-03-024Oakes Gregory — Chief Executive Officer, DirectorGrant/award (A): 475,300 (derivative) @ $0EDGAR
2023-03-024Truesdell Patrick — Vice President and ControllerGrant/award (A): 99,600 (derivative) @ $0 · Grant/award (A): 99,600 (derivative) @ $0EDGAR
2023-01-114PERCEPTIVE ADVISORS LLC — 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — 10% owner
Perceptive Xontogeny Venture Fund, LP — 10% owner
Perceptive Xontogeny Venture Fund II, LP — 10% owner
EDELMAN JOSEPH — 10% owner
Purchase (P): 27,272,727 (derivative) @ $0.54 · Purchase (P): 3,636,363 (derivative) @ $0.54EDGAR
2022-09-274RTW INVESTMENTS, LP — 10% owner
WONG RODERICK — 10% owner
Sale (S): 300,000 @ $0.69EDGAR
2022-09-074Cataldi Fabio — Chief Medical OfficerGrant/award (A): 400,000 (derivative) @ $0EDGAR
2022-08-094Bassaganya-Riera Josep — 10% ownerGift (G): 500,000 @ $0 · Gift (G): 500,000 @ $0EDGAR
2022-06-224Oakes Gregory — Chief Executive Officer, DirectorGrant/award (A): 1,677,251 (derivative) @ $0EDGAR
2022-06-224MAYLEBEN TIMOTHY M — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2022-06-094Callori Fred — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2022-06-094Garabedian Christopher Nishan — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2022-06-094Adsett Roger — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2022-06-094Girao Tiago — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2022-05-184Callori Fred — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2022-05-184Garabedian Christopher Nishan — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2022-05-184Girao Tiago — DirectorGrant/award (A): 18,000 (derivative) @ $0EDGAR
2022-03-104Adsett Roger — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2021-12-214BITAR PATRICIA L — Interim CFOGrant/award (A): 87,513 (derivative) @ $0EDGAR
2021-12-214MAYLEBEN TIMOTHY M — Interim CEO, DirectorGrant/award (A): 253,485 (derivative) @ $0EDGAR
2021-12-204Bassaganya-Riera Josep — 10% ownerGift (G): 58,651 @ $0 · Sale (S): 24,301 @ $5.11 · Sale (S): 36,000 @ $4.84 · Sale (S): 33,194 @ $4.75EDGAR
2021-12-154Bassaganya-Riera Josep — 10% ownerSale (S): 40,000 @ $5.37 · Sale (S): 42,000 @ $5.10 · Sale (S): 43,000 @ $5.02EDGAR
2021-12-104Bassaganya-Riera Josep — 10% ownerSale (S): 11,162 @ $6.26 · Sale (S): 40,000 @ $5.77EDGAR
2021-12-084Bassaganya-Riera Josep — 10% ownerSale (S): 36,000 @ $6.17 · Sale (S): 42,000 @ $6.58 · Sale (S): 25,530 @ $6.65EDGAR
2021-12-034Bassaganya-Riera Josep — 10% ownerSale (S): 32,237 @ $7.01 · Sale (S): 29,861 @ $6.45 · Sale (S): 36,000 @ $6.15 · Gift (G): 934,504 @ $0 · Gift (G): 934,504 @ $0EDGAR
2021-12-014Bassaganya-Riera Josep — 10% ownerSale (S): 15,430 @ $7.58 · Sale (S): 35,000 @ $7.06EDGAR
2021-11-184Chauhan Jyoti — ED, Global Clinical OperationsOption exercise (M): 118,054 @ $1.86 · Option exercise (M): 118,054 (derivative) @ $0EDGAR
2021-08-314Callori Fred — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2021-08-314Xontogeny, LLC — DirectorGrant/award (A): 10,709 (derivative) @ $0EDGAR
2021-08-314PERCEPTIVE ADVISORS LLC — Director, 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — Director
Perceptive Xontogeny Venture Fund, LP — Director
EDELMAN JOSEPH — Director
Grant/award (A): 25,291 (derivative) @ $0EDGAR
2021-05-174MAYLEBEN TIMOTHY M — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2021-04-124Girao Tiago — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2021-02-094Poukalov Konstantin — Director, 10% ownerPurchase (P): 27,453 @ $11.14 · Purchase (P): 34,611 @ $11.38 · Purchase (P): 86,671 @ $12.53 · Purchase (P): 1,771 @ $13.10 · Purchase (P): 64,730 @ $13.80 · Purchase (P): 34,951 @ $14.60EDGAR
2021-02-094PERCEPTIVE ADVISORS LLC — Director, 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — Director, 10% owner
Xontogeny, LLC — Director, 10% owner
Perceptive Xontogeny Venture Fund, LP — Director, 10% owner
EDELMAN JOSEPH — Director, 10% owner
Purchase (P): 27,453 @ $11.14 · Purchase (P): 34,611 @ $11.38 · Purchase (P): 86,671 @ $12.53 · Purchase (P): 1,771 @ $13.10 · Purchase (P): 64,730 @ $13.80 · Purchase (P): 34,951 @ $14.60EDGAR

Recent 8-K events — Landos Biopharma, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-05-238-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2024-05-238-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-03-258-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-03-218-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-048-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-218-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-09-218-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-09-148-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=LABP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs